Cytosorbents Corp
CTSO
49 hedge funds and large institutions have $27.7M invested in Cytosorbents Corp in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 5 closing their positions.
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
133% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 9
124% more call options, than puts
Call options by funds: $1.05M | Put options by funds: $468K
33% more capital invested
Capital invested by funds: $20.9M → $27.7M (+$6.83M)
14% more funds holding
Funds holding: 43 → 49 (+6)
2.19% more ownership
Funds ownership: 11.13% → 13.32% (+2.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.67M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.11M |
| 3 |
Two Sigma Investments
New York
|
+$715K |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$650K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$587K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BRF
B. Riley Financial
Los Angeles,
California
|
-$992K |
| 2 |
PG
PEAK6 Group
Chicago,
Illinois
|
-$648K |
| 3 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
-$292K |
| 4 |
Barclays
London,
United Kingdom
|
-$194K |
| 5 |
AGM
Alpine Global Management
New York
|
-$115K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PG
51
PEAK6 Group
Chicago,
Illinois
| – | -$648K | -99,744 | Closed |
|
|
AGM
52
Alpine Global Management
New York
| – | -$115K | -17,689 | Closed |
|
|
ARTA
53
A.R.T. Advisors
New York
| – | -$69K | -10,647 | Closed |
|
54
JP Morgan Chase
New York
| – | -$39K | -6,000 | Closed |
|
CTSO Hedge Fund Activity: Q1 2018 in Review
49 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q1 2018, worth a combined $27.7M — up 33% from $20.9M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new CTSO positions and 5 closed out — a net gain of 7 holders — while 21 added to existing stakes and 9 trimmed.
The largest buyer was Millennium Management, adding an estimated $1.67M. The largest seller was B. Riley Financial, exiting entirely with an estimated $992K sold.
- 49 institutional investors held Cytosorbents Corp (CTSO) as of Q1 2018, up from 43 in Q4 2017.
- Funds reported $27.7M of Cytosorbents Corp stock for Q1 2018, up 33% quarter-over-quarter.
- 12 funds opened new Cytosorbents Corp positions in Q1 2018 and 5 closed out, a net change of +7 holders.
- The largest Cytosorbents Corp buyer in Q1 2018 was Millennium Management, an estimated $1.67M added.
- The largest Cytosorbents Corp seller in Q1 2018 was B. Riley Financial, an estimated $992K sold.
Based on aggregated 13F filings for Q1 2018.